AMANDA MACLEOD: Open Payments
NPI 1558042259 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 30 payments from 7 companies in 2025. Trend: 2023 $373 · 2024 $760 · 2025 $863
Food & beverage: $762Education: $101
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $424 |
| Teva Pharmaceuticals USA, Inc. | 5 | $193 |
| Alkermes, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $88 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: VRAYLAR, ARISTADA, TRINTELLIX, UZEDY, AUSTEDO XR, INGREZZA, SPRAVATO, CAPLYTA.
Industry payments across CO — which companies pay providers there.
